We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
-4.15%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$1.68B
AUM Growth
+$769M
Cap. Flow
+$831M
Cap. Flow %
49.48%
Top 10 Hldgs %
8.16%
Holding
2,474
New
799
Increased
624
Reduced
373
Closed
629

Sector Composition

Rank Sector Weight
1 Healthcare 1.91%
2 Technology 1.1%
3 Consumer Discretionary 1.05%
4 Communication Services 0.58%
5 Materials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAL icon
1776
PUT
Caleres
CAL
$420M
$9K ﹤0.01%
+400
New +$7.55K
TDC icon
1777
Teradata
TDC
$2.8B
$9K ﹤0.01%
300
UTHR icon
1778
United Therapeutics
UTHR
$26.3B
$9K ﹤0.01%
110
PRAH
1779
DELISTED
PRA Health Sciences, Inc.
PRAH
$9K ﹤0.01%
90
CVSA
1780
PUT
Covista Inc
CVSA
$4.09B
$8K ﹤0.01%
+200
New +$8.98K
CHRW icon
1781
PUT
C.H. Robinson
CHRW
$20.6B
$8K ﹤0.01%
+100
New +$8.4K
NOW icon
1782
ServiceNow
NOW
$109B
$8K ﹤0.01%
150
-550
-79% -$29.9K
RYAM icon
1783
CALL
Rayonier Advanced Materials
RYAM
$573M
$8K ﹤0.01%
1,800
-3,300
-65% -$14.1K
SPTN
1784
CALL
DELISTED
SpartanNash
SPTN
$8K ﹤0.01%
700
-71,700
-99% -$807K
TWOU
1785
PUT
DELISTED
2U Inc
TWOU
$8K ﹤0.01%
+17
New +$12.2K
BHVN
1786
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8K ﹤0.01%
+200
New +$8.45K
CHKP icon
1787
Check Point Software Technologies
CHKP
$13.6B
$7K ﹤0.01%
+60
New +$6.69K
CRL icon
1788
Charles River Laboratories
CRL
$10.8B
$7K ﹤0.01%
50
HUYA
1789
Huya Inc
HUYA
$558M
$7K ﹤0.01%
300
-22,930
-99% -$541K
LH icon
1790
Labcorp
LH
$24.7B
$7K ﹤0.01%
+47
New +$6.86K
PHM icon
1791
PUT
Pultegroup
PHM
$24.9B
$7K ﹤0.01%
200
-10,600
-98% -$353K
P
1792
Everpure Inc
P
$24.7B
$7K ﹤0.01%
+400
New +$6.27K
VIAV icon
1793
PUT
Viavi Solutions
VIAV
$9.41B
$7K ﹤0.01%
+500
New +$7.11K
WWE
1794
CALL
DELISTED
World Wrestling Entertainment
WWE
$7K ﹤0.01%
100
-6,900
-99% -$494K
WBT
1795
DELISTED
Welbilt, Inc.
WBT
$7K ﹤0.01%
+400
New +$6.49K
GIX.RT
1796
DELISTED
GigCapital2, Inc. Rights, each exchangeable into one-twentieth of a share of Common Stock
GIX.RT
$7K ﹤0.01%
+25,000
New +$4.56K
TLRD
1797
CALL
DELISTED
Tailored Brands, Inc.
TLRD
$7K ﹤0.01%
1,700
S
1798
DELISTED
Sprint Corporation
S
$7K ﹤0.01%
+1,200
New +$8.26K
ATHM icon
1799
Autohome
ATHM
$2.46B
$6K ﹤0.01%
+70
New +$6K
CROX icon
1800
Crocs
CROX
$6.69B
$6K ﹤0.01%
200
-3,268
-94% -$79.2K

Similar funds

Walleye Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Walleye Capital held 2,474 positions worth $1.68B, up 84% from $910M the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Walleye Capital deployed $831M of net new capital in Q3 2019, opening 799 new positions and adding to 624 existing holdings. Its largest new stake was Meta Platforms (Facebook): 13,918 shares worth $2.48M.

By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 1.8% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Arqule Inc, an estimated $1.22M trimmed.

  • Walleye Capital's largest Q3 2019 buy was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
  • Walleye Capital added most to Abiomed Inc in Q3 2019, an estimated $2.42M increase.
  • Walleye Capital's biggest Q3 2019 reduction was Arqule Inc, cutting an estimated $1.22M.
  • Walleye Capital fully exited 8i Enterprises Acquisition Corp Unit in Q3 2019, selling an estimated $1.58M.
  • Walleye Capital's ten largest holdings make up 8.2% of its $1.68B portfolio in Q3 2019.
  • Walleye Capital opened 799 new positions and closed 629 in Q3 2019.
  • Walleye Capital's portfolio value rose 84% quarter-over-quarter to $1.68B.

Based on Walleye Capital's 13F filing for Q3 2019, filed 14 Nov 2019.